Every month the ISN-ACT Team lists interesting new randomized controlled trials (RCTs) from around the world.
Highlight:
LOL-HD study: Laughter therapy may reduce depressive symptoms in hemodialysis patients
See the latest trials here.
A summary of the highlighted trial is now available in French, Spanish, and Mandarin.
Support equal access to nephrology research: Become an ISN Member!
The ISN has expanded its “Cardio-Kidney-Metabolic (CKM) Initiative” with the launch... read more
A groundbreaking study led by ISN members as part of the... read more
In September, the ISN launched an online petition urging everyone to... read more
Two significant research studies were accepted as late-breaking clinical trials at... read more
ISN Fellow Ahmad Naseer Kaihan, from Afghanistan, completed an intensive 12-month... read more
The “Primer Course in Glomerular Diseases” offers comprehensive updates on glomerulonephritis... read more
Kidney International® A Randomized, Open-label Clinical Trial Examined the Effects of Canagliflozin... read more
The ISN PARADIGM meeting took place in Vancouver, BC, Canada, from... read more
Brussels, November 26, 2024 The International Society of Nephrology (ISN) is pleased... read more
The ISN endorses high-quality educational and scientific events worldwide in the... read more
